For Immediate Release
Award-Winning Thyroid Research Published in American Thyroid Association’s Official Journal
Contact: Vicki Cohn
New Rochelle, NY, January 11, 2013—Each year the American Thyroid Association confers two prestigious prizes for the best basic science paper and the best clinical paper published in its official journal, Thyroid. The two papers that garnered the 2012 prizes are available free on the Thyroid website.
Papers nominated for the Thyroid Prize by the Thyroid Prize Committee composed of Rebecca S. Bahn, Quan-Yang Duh, Marian E. Ludgate, Furio Pacini, Elizabeth Pearce, Douglas Ross, Cord Sturgeon, and Theo Visser. The committee was chaired by Peter A. Kopp. The winners were selected from the nominated papers by the Editorial Board and Editors.
The winner of the best basic science paper is “Small-Molecule Thyrotropin Receptor Agonist Activates Naturally Occurring Thyrotropin-Insensitive Mutants and Reveals Their Distinct Cyclic Adenosine Monophosphate Signal Persistence” by Michael D. Allen, Susanne Neumann, and Marvin C. Gershengorn from the Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
The prize-winning best clinical paper is “Enhanced Survival in Locoregionally Confined Anaplastic Thyroid Carcinoma: A Single-Institution Experience Using Aggressive Multimodal Therapy” by Robert L. Foote, Julian R. Molina, Jan L. Kasperbauer, Ricardo V. Lloyd, Bryan McIver, John C. Morris, Clive S. Grant, Geoffrey B. Thompson, Melanie L. Richards, Ian D. Hay, Robert C. Smallridge, and Keith C. Bible from Mayo Clinic, Rochester, MN.
"These two outstanding papers highlight the quality of basic, translational, and clinical research submitted to Thyroid,” says Bryan R. Haugen, MD, President of the ATA and Professor of Medicine and Pathology, Head, Division of Endocrinology, Metabolism & Diabetes, Mary Rossick Kern and Jerome H. Kern Chair in Endocrine Neoplasms Research, University of Colorado School of Medicine. “Allen and colleagues provide insights into the basic biology of TSH signaling and use a translational approach to characterize novel small molecule TSHR agonists, while Foote and colleagues provide a clinical tour de force in newer and more successful treatments for patients with anaplastic thyroid cancer.”
“It is always a challenging task to select the winners given the large number of high quality papers, and there were several strong finalists in both categories,” says Peter A. Kopp, MD, Editor-in-Chief of Thyroid and Associate Professor of Medicine, Division of Endocrinology, Metabolism and Molecular Medicine, and Director ad interim of the Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago. “The spectrum of outstanding manuscripts that were among the finalists reflects that Thyroid is the premier journal focusing exclusively on clinical and basic thyroidology.”
About the Society
The American Thyroid Association (ATA) is the leading worldwide organization dedicated to the advancement, understanding, prevention, diagnosis and treatment of thyroid disorders and thyroid cancer. ATA is an international membership medical society with over 1,600 members from 43 countries around the world. Celebrating its 90th anniversary, ATA delivers its mission through several key endeavors: the publication of highly regarded monthly journals, Thyroid, Clinical Thyroidology and Clinical Thyroidology for Patients; annual scientific meetings; biennial clinical and research symposia; research grant programs for young investigators, support of online professional, public and patient educational programs; and the development of guidelines for clinical management of thyroid disease. The ATA has extensive online information on their website on thyroid disease for patients in both English and Spanish and serves as the clinical resource for patients and the public who look for reliable information on the Internet.
About the Journal
Thyroid, the Official Journal of the American Thyroid Association, is an authoritative peer-reviewed Journal published monthly in print and online. The Journal publishes original articles and timely reviews that reflect the rapidly advancing changes in our understanding of thyroid physiology and pathology, from the molecular biology of the cell to clinical management of thyroid disorders. Complete tables of content and a sample issue may be viewed online on the Thyroid website.
About the Publisher
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Diabetes Technology & Therapeutics, Journal of Women’s Health, and Metabolic Syndrome and Related Disorders. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 70 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.